Question from Deputy Ken O’Flynn - PQ 39837-26
Deputy O'Flynn asked about the average period between European Medicines Agency authorisation and final reimbursement decision for orphan medicines.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the average period between European Medicines Agency authorisation and final reimbursement decision for orphan medicines.
Deputy O'Flynn asked about the number of orphan or ultra-rare disease medicines which received a negative reimbursement recommendation. Read the HSE response.
Deputy O'Flynn asked about the reimbursement of omaveloxolone (skyclarys) for individuals with Friedreich's ataxia. Read the HSE response.
Deputy Quaide asked about adult residential disability services in Dublin. Read the HSE response.
Deputy Quaide asked about residential services in the Dublin south-east and Dublin and north-east health regions. Read the HSE response.
Deputy Brabazon asked about the number of cancelled operations at Beaumont Hospital, the Mater Hospital, St. James's Hospital and CHI. Read the HSE response.
Deputy Quaide asked about residential disability services in Dublin. Read the HSE response.
Deputy O'Gorman asked about the waiting lists for CDNT Services in Tipperary. Read the HSE response.
Deputy Quaide asked about residential care services for children. Read the HSE response.
Deputy Burke asked about the supports available through the HSE QUIT smoking cessation service. Read the HSE response.